Response to the Comment on "The Effect of Postoperative Complications After Minimally Invasive Esophagectomy on Long-term Survival: An International Multicenter Cohort Study"

Affiliations

Comment

Laura F C Fransen et al. Ann Surg. 2021.

. 2021 Dec 1;274(6):e741-e742.

doi: 10.1097/SLA.0000000000004293.

No abstract available

Conflict of interest statement

The authors declare no conflicts of interest.

The Effect of Postoperative Complications After Minimally Invasive Esophagectomy on Long-term Survival: An International Multicenter Cohort Study.
Fransen LFC, Berkelmans GHK, Asti E, van Berge Henegouwen MI, Berlth F, Bonavina L, Brown A, Bruns C, van Daele E, Gisbertz SS, Grimminger PP, Gutschow CA, Hannink G, Hölscher AH, Kauppi J, Lagarde SM, Mercer S, Moons J, Nafteux P, Nilsson M, Palazzo F, Pattyn P, Raptis DA, Räsanen J, Rosato EL, Rouvelas I, Schmidt HM, Schneider PM, Schröder W, van der Sluis PC, Wijnhoven BPL, Nieuwenhuijzen GAP, Luyer MDP; EsoBenchmark Collaborative. Fransen LFC, et al. Ann Surg. 2021 Dec 1;274(6):e1129-e1137. doi: 10.1097/SLA.0000000000003772. Ann Surg. 2021. PMID: 31972650
Comment on "The Effect of Postoperative Complications After Minimally Invasive Esophagectomy on Long-term Survival: An International Multicenter Cohort Study".
Zhang G, Zhang H, Li Q, Li J, Li X. Zhang G, et al. Ann Surg. 2021 Dec 1;274(6):e740-e741. doi: 10.1097/SLA.0000000000004288. Ann Surg. 2021. PMID: 33055580 No abstract available.

1. Fransen LFC, Berkelmans GHK, Asti E, et al. The effect of postoperative complications after minimally invasive esophagectomy on long-term survival: an international multicenter cohort study. Ann Surg 2020; doi: 10.1097/SLA.0000000000003772. [Published online ahead of print, Ann Surg. 2020 Jan 14]. - DOI
1. Schmidt HM, Gisbertz SS, Moons J, et al. Defining benchmarks for transthoracic esophagectomy. Ann Surg 2017; 266:814–821.
1. Low DE, Alderson D, Cecconello I, et al. International consensus on standardization of data collection for complications associated with esophagectomy: esophagectomy complications consensus group (ECCG). Ann Surg 2015; 262:286–294.
1. Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and othermodalities. Lancet Oncol 2007; 8:545–553.
1. Stahl M, Walz MK, Stuschke M, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 2009; 27:851–856.